Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: A predictive panel

Diseases of the Colon and Rectum

Volumn 53, Issue 1, 2010, Pages 31-38

  Chen, Zhiguo ^a   Li, Ming ^a   Yuan, Yanhua ^a   Wang, Qi ^a   Yan, Li ^a   Gu, Jin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Cancer testis antigen; Colorectal cancer; Liver metastasis; Predictive panel

Indexed keywords

CANCER TESTIS ANTIGEN; PROTEIN PAGE4; SCP 1 PROTEIN; SPANX PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; NUCLEAR PROTEIN; PAGE4 PROTEIN, HUMAN; PARACETAMOL; SACCHARIN; SCP 1; SPANXA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EMBOLISM; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHENOTYPE; PREDICTIVE VALIDITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TUMOR GENE; COLORECTAL TUMOR; GENETICS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ACETAMINOPHEN; ADULT; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RISK FACTORS; SACCHARIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 73449120434     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181bdca3a     Document Type: Article

References (30)

1. Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47:1269-1284
2. Lau WY, Lai EC. Hepatic resection for colorectal liver metastases. Singapore Med J. 2007;48:635-639
3. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer. 2002;38:1023-1033
4. Old LJ. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun. 2001;1:1.
5. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254:1643-1647
6. Sienel W, Varwerk C, Linder A, et al. Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study. Eur J Cardiothorac Surg. 2004;25:131-134
7. Gure AO, Chua R, Williamson B, et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res. 2005;11:8055-8062
8. Westbrook VA, Schoppee PD, Diekman AB, et al. Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res. 2004;10:101-112
9. Patard JJ, Brasseur F, Gil-Diez S, et al. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer. 1995;64:60-64
10. Li M, Yuan YH, Han Y, et al. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Clin Cancer Res. 2005;11:1809-1814
11. Greene FL, Compton CC, Fritz AG, et al. American Joint Committee on Cancer. AJCC cancer staging atlas New York, NY: Springer, 2006.
12. Iwata T, Fujita T, Hirao N, et al. Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer. Clin Cancer Res. 2005; 11:3949-3957
13. Gerhardt A, Usener D, Keese M, Sturm J, Schadendorf D, Eichmuller S. Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer. Cancer Lett. 2004;208:197-206.
14. Heidebrecht HJ, Claviez A, Kruse ML, et al. Characterization and expression of CT45 in Hodgkin's lymphoma. Clin Cancer Res. 2006;12:4804-4811
15. Dong XY, Su YR, Qian XP, et al. Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients. Br J Cancer. 2003;89:291-297
16. Adams SP, Sahota SS, Mijovic A, et al. Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia. 2002;16:2238-2242
17. Park JW, Kwon TK, Kim IH, et al. A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods. 2002; 266:79-86.
18. Kong U, Koo J, Choi K, Park J, Chang H. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer. Hepatogastroenterology. 2004;51: 1519-1523
19. Barrett A, Madsen B, Copier J, et al. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int J Cancer. 2002;101:581-588
20. Wang Z, Zhang Y, Liu H, Salati E, Chiriva-Internati M, Lim SH. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood. 2003;101: 955-960
21. Ono T, Kurashige T, Harada N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci U S A. 2001;98:3282-3287
22. Alves PM, Levy N, Bouzourene H, et al. Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother. 2007;56:839-847
23. Bernards R, Weinberg RA. A progression puzzle. Nature. 2002; 418:823.
24. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-458
25. Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B viruspositive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003;9:416-423
26. Adib TR, Henderson S, Perrett C, et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer. 2004;90:686-692
27. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999-2009.
28. Zambon A, Mandruzzato S, Parenti A, et al. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer. 2001;91:1882-1888
29. Cheung IY, Chi SN, Cheung NK. Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma. Med Pediatr Oncol. 2000;35: 632-634
30. Tammela J, Jungbluth AA, Qian F, et al. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer. Cancer Immun. 2004; 4:10.